All subcategories » published RCT
A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis.
primary studies published RCT
Details- 2020
- McWilliam SJ
CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trials.
primary studies published RCT
Details- 2019
- Bell SC
Non-invasive ventilation versus oxygen therapy in cystic fibrosis: A 12-month randomized trial.
primary studies published RCT
Details- 2019
- Milross MA
Lumacaftor/Ivacaftor reduces pulmonary exacerbations in patients irrespective of initial changes in FEV1.
primary studies published RCT
Details- 2019
- McColley SA
Impact of hypertonic saline nebulisation combined with oscillatory positive expiratory pressure on sputum expectoration and related symptoms in cystic fibrosis: a randomised crossover trial.
primary studies published RCT
Details- 2019
- San Miguel-Pagola M
Exenatide corrects postprandial hyperglycaemia in young people with cystic fibrosis and impaired glucose tolerance: A randomized crossover trial.
primary studies published RCT
Details- 2019
- Geyer MC
Dornase alfa during lower respiratory tract infection post-lung transplantation: a randomized controlled trial.
primary studies published RCT
Details- 2019
- Tarrant BJ
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial.
primary studies published RCT
Details- 2019
- Heijerman HGM
Sildenafil improves exercise capacity in patients with cystic fibrosis: a proof-of-concept clinical trial.
primary studies published RCT
Details- 2019
- Rodriguez-Miguelez P
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele.
primary studies published RCT
Details- 2019
- Middleton PG